Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

NCT03945175 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03945175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03945175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening
Lead sponsor
NYU Langone Health
Phase
Phase 3
Overall status
Completed
Start date
July 15, 2020
Completion date
May 11, 2022
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit-hyperactivity